Comparative Adverse Event Reporting of Asparaginase-Containing Induction Regimens in Pediatric Acute Lymphoblastic Leukemia Using the United States Food and Drug Administration Adverse Event Reporting System. [PDF]
Ogura T, Shiraishi C.
europepmc +1 more source
Streptomyces koyangensis L-asparaginase: computational prediction of dual-mechanism BCL-2 interaction in acute lymphoblastic leukemia. [PDF]
Solanki G +5 more
europepmc +1 more source
Pharmacogenomics of treatment toxicities in pediatric B-Cell ALL: toward safer precision therapy. [PDF]
Lameri M +14 more
europepmc +1 more source
Prevalence and Risk Factors of Acute Pancreatitis in Childhood Acute Leukemia. [PDF]
Thepuatrakul K +6 more
europepmc +1 more source
Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity. [PDF]
Lefeivre T +11 more
europepmc +1 more source
Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCT. [PDF]
Eng DZS +16 more
europepmc +1 more source
A Rare Primary Adrenal Malignancy Manifesting as a Hemorrhagic Mass: Case Report and Literature Review. [PDF]
Ghaithi SA +3 more
europepmc +1 more source
Ocular and Orbital Involvement in Extranodal Natural Killer/T-cell Lymphoma: A Systematic Review of Clinical Outcomes and Prognostic Factors. [PDF]
Buttar RK +6 more
europepmc +1 more source
Overcoming challenges in the production of a human-like L-asparaginase: advanced strategies for expression and purification. [PDF]
Pinheiro MP +5 more
europepmc +1 more source
Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL. [PDF]
Anderson DR +34 more
europepmc +1 more source

